A study of the methodological and clinical validity of the combined lactulose hydrogen breath test with scintigraphic oro‐cecal transit test for diagnosing small intestinal bacterial overgrowth in IBS patients
Authors:
- 18 March 2014
- journal article
- research article
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 26 (6) , 794-802
Abstract
Background: Small intestinal bacterial overgrowth (SIBO) may be a cause of irritable bowel syndrome (IBS); however, current investigations have important limitations. We aimed to identify clinically relevant diagnostic criteria for SIBO based on lactulose hydrogen breath test (LHBT) alone and combined with scintigraphic measurement of oro‐cecal transit (SOCT).Methods: Results of LHBT/SOCT investigation from 89 IBS patients and 13 healthy volunteers were included in a systematic analysis of six published criteria for SIBO diagnosis. Clinical relevance of competing criteria was determined by assessing (i) prevalence of SIBO in IBS patients and healthy volunteers (ii) if SIBO diagnosis predicted improvement in IBS symptoms in a prospective, pilot therapeutic trial of a non‐absorbable antibiotic (rifaximin 600 mg b.d.) in IBS patients.Key Results: Reproducibility of SIBO diagnosis by combined LHBT/SOCT was near perfect. A ≥5 ppm H2 increase prior to appearance of cecal contrast was detected in more IBS patients than healthy volunteers (35/89 vs 1/13; p = 0.026), but not for other diagnostic criteria. IBS patients with SIBO, compared to those without SIBO, reported significantly greater improvement in abdominal symptoms following rifaximin therapy (p < 0.002 overall IBS symptom severity). This improvement was most marked in D‐IBS patients in whom all symptoms improved, including stool frequency and consistency (all p < 0.004).Conclusions & Inferences: Combined LHBT/SOCT testing using a H2 5 ppm cutoff may identify a subgroup of IBS patients with SIBO. Pilot data examining the clinical response to rifaximin suggest that this subset of IBS patients may benefit more than those with a normal test.Keywords
This publication has 36 references indexed in Scilit:
- Prevalence and Presentation of Lactose Intolerance and Effects on Dairy Product Intake in Healthy Subjects and Patients With Irritable Bowel SyndromeClinical Gastroenterology and Hepatology, 2013
- Combined Orocecal Scintigraphy and Lactulose Hydrogen Breath Testing Demonstrate that Breath Testing Detects Orocecal Transit, Not Small Intestinal Bacterial Overgrowth in Patients With Irritable Bowel SyndromeGastroenterology, 2011
- Rifaximin Therapy for Patients with Irritable Bowel Syndrome without ConstipationNew England Journal of Medicine, 2011
- Lactose intolerance in patients with chronic functional diarrhoea: the role of small intestinal bacterial overgrowthAlimentary Pharmacology & Therapeutics, 2010
- Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors?BMC Gastroenterology, 2010
- A Systematic Review of Diagnostic Tests for Small Intestinal Bacterial OvergrowthDigestive Diseases and Sciences, 2007
- Small intestinal bacterial overgrowth in patients with irritable bowel syndromeGut, 2006
- Interpretation of the breath hydrogen profile obtained after ingesting a solid meal containing unabsorbable carbohydrate.Gut, 1985
- Incomplete Absorption of the Carbohydrate in All-Purpose Wheat FlourNew England Journal of Medicine, 1981
- Intestinal absorption of carbohydrates in manProceedings of the Nutrition Society, 1971